Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $168,264 | 73 | 61.8% |
| Consulting Fee | $34,740 | 13 | 12.8% |
| Travel and Lodging | $25,493 | 108 | 9.4% |
| Honoraria | $20,670 | 12 | 7.6% |
| Food and Beverage | $20,575 | 661 | 7.6% |
| Unspecified | $2,294 | 7 | 0.8% |
| Education | $371.23 | 7 | 0.1% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Products, LP | $102,744 | 134 | $0 (2023) |
| Merck Sharp & Dohme LLC | $81,380 | 129 | $0 (2024) |
| ViiV Healthcare Company | $31,221 | 189 | $0 (2024) |
| Theratechnologies Inc. | $28,184 | 56 | $0 (2024) |
| Gilead Sciences, Inc. | $17,692 | 185 | $0 (2024) |
| Napo Pharmaceuticals Inc | $4,258 | 8 | $0 (2018) |
| GlaxoSmithKline, LLC. | $2,310 | 8 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $1,924 | 10 | $0 (2023) |
| Janssen Biotech, Inc. | $1,549 | 108 | $0 (2023) |
| EMD Serono, Inc. | $773.81 | 35 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,965 | 83 | ViiV Healthcare Company ($1,852) |
| 2023 | $23,848 | 123 | Janssen Products, LP ($14,776) |
| 2022 | $43,723 | 77 | Janssen Products, LP ($27,491) |
| 2021 | $14,734 | 82 | Theratechnologies Inc. ($8,052) |
| 2020 | $28,849 | 48 | ViiV Healthcare Company ($10,216) |
| 2019 | $53,323 | 172 | Merck Sharp & Dohme Corporation ($19,192) |
| 2018 | $35,558 | 136 | Janssen Products, LP ($19,860) |
| 2017 | $69,406 | 160 | Merck Sharp & Dohme Corporation ($26,344) |
All Payment Transactions
881 individual payment records from CMS Open Payments — Page 1 of 36
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.80 | General |
| 12/03/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $25.78 | General |
| 11/21/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.46 | General |
| 11/11/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $34.73 | General |
| Category: HIV | ||||||
| 10/31/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.72 | General |
| 10/29/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.88 | General |
| 10/28/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: HIV | ||||||
| 10/28/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $2.41 | General |
| Category: HIV | ||||||
| 10/24/2024 | Theratechnologies Inc. | EGRIFTA (Drug), TROGARZO | Food and Beverage | In-kind items and services | $82.42 | General |
| Category: HIV | ||||||
| 10/21/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO | Food and Beverage | In-kind items and services | $28.67 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/18/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $26.00 | General |
| Category: HIV | ||||||
| 10/16/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: HIV | ||||||
| 10/15/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.98 | General |
| 10/02/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $20.14 | General |
| 10/01/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: HIV | ||||||
| 09/27/2024 | ViiV Healthcare Company | — | Travel and Lodging | In-kind items and services | $336.38 | General |
| 09/27/2024 | ViiV Healthcare Company | — | Food and Beverage | In-kind items and services | $103.33 | General |
| 09/27/2024 | ViiV Healthcare Company | — | Food and Beverage | In-kind items and services | $51.73 | General |
| 09/27/2024 | ViiV Healthcare Company | — | Food and Beverage | In-kind items and services | $27.59 | General |
| 09/26/2024 | ViiV Healthcare Company | — | Travel and Lodging | In-kind items and services | $28.00 | General |
| 09/26/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: HIV | ||||||
| 09/26/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.33 | General |
| 09/25/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.87 | General |
| 09/24/2024 | Theratechnologies Inc. | EGRIFTA SV (Drug) | Food and Beverage | In-kind items and services | $48.21 | General |
| Category: HIV | ||||||
| 09/18/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: Diabetes | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A PHASE IIIB, MULTI-CENTER, NON-RANDOMIZED, PARALLEL-GROUP, OPEN-LABEL | GlaxoSmithKline, LLC. | $2,294 | 7 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 80 | 140 | $28,459 | $5,694 |
| 2022 | 2 | 24 | 49 | $4,468 | $1,301 |
| 2021 | 2 | 24 | 57 | $3,630 | $2,171 |
| 2020 | 1 | 11 | 17 | $1,700 | $969.98 |
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 30 | 51 | $13,583 | $2,696 | 19.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 23 | 37 | $14,356 | $2,561 | 17.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 27 | 52 | $520.00 | $436.80 | 84.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 12 | 25 | $4,058 | $1,230 | 30.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 12 | 24 | $410.00 | $71.01 | 17.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 13 | 34 | $3,400 | $2,102 | 61.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 11 | 23 | $230.00 | $69.00 | 30.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 11 | 17 | $1,700 | $969.98 | 57.1% |
About Dr. Sheetal Sharma, MD
Dr. Sheetal Sharma, MD is a Internal Medicine healthcare provider based in Fort Lauderdale, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1245295336.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sheetal Sharma, MD has received a total of $272,407 in payments from pharmaceutical and medical device companies, with $2,965 received in 2024. These payments were reported across 881 transactions from 19 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($168,264).
As a Medicare-enrolled provider, Sharma has provided services to 139 Medicare beneficiaries, totaling 263 services with total Medicare billing of $10,136. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Fort Lauderdale, FL
- Active Since 04/20/2006
- Last Updated 05/08/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1245295336
Products in Payments
- SYMTUZA (Drug) $45,410
- ISENTRESS (Drug) $37,695
- PREZCOBIX (Drug) $25,686
- DELSTRIGO (Drug) $24,815
- TROGARZO (Drug) $24,659
- Symtuza (Drug) $15,879
- DOVATO (Drug) $11,916
- PIFELTRO (Drug) $8,569
- ZEPATIER (Drug) $5,415
- Genvoya (Drug) $5,218
- Mytesi (Drug) $4,258
- Descovy (Drug) $3,136
- APRETUDE (Biological) $752.61
- EGRIFTA (Drug) $516.01
- CABENUVA (Biological) $493.01
- SEROSTIM (Biological) $241.10
- JULUCA (Drug) $208.76
- EGRIFTA SV (Drug) $158.98
- SEROSTIM (Drug) $153.27
- TRIUMEQ (Drug) $141.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Fort Lauderdale
Keith Rubin, M.d, M.D
Internal Medicine — Payments: $2.0M
Michael Sension, Md, MD
Internal Medicine — Payments: $1.1M
Bernard Garcia, Md, MD
Internal Medicine — Payments: $499,841
Joshua Lenchus, Do, DO
Internal Medicine — Payments: $82,782
Alan Graff, Md, MD
Internal Medicine — Payments: $29,238
Maxine Hamilton, Md, MD
Internal Medicine — Payments: $27,993